Lacidipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension
C Rhoda Lee, HM Bryson - Drugs, 1994 - Springer
Synopsis Lacidipine is an orally administered calcium channel blocker of the
dihydropyridine class, which shows selectivity for vascular smooth muscle over cardiac …
dihydropyridine class, which shows selectivity for vascular smooth muscle over cardiac …
Lacidipine: a review of its use in the management of hypertension
PL McCormack, AJ Wagstaff - Drugs, 2003 - Springer
Summary Abstract Lacidipine (Caldine®, Lacimen®, Lacipil®, Midotens®, Motens®) is a
once-daily, orally-administered, lipophilic dihydropyridine calcium antagonist with an …
once-daily, orally-administered, lipophilic dihydropyridine calcium antagonist with an …
[图书][B] Hagers Handbuch der Pharmazeutischen Praxis: Drogen E—O
H Hager, S Greiner, G Heubl, E Stahl-Biskup - 2013 - books.google.com
Der zweite Band des Gebietes Drogen der Neuauflage enthält in alphabetischer
Reihenfolge von EO Monographien über Arzneipflanzengattungen. Jede Monographie …
Reihenfolge von EO Monographien über Arzneipflanzengattungen. Jede Monographie …
Oral lacidipine in the treatment of anal fissure
L Ansaloni, A Bernabe, R Ghetti, R Riccardi… - Techniques in …, 2002 - Springer
The aim of this prospective study was to assess the effectiveness in healing anal fissure (AF)
of lacidipine, a calcium channel blocker with a better tolerability in comparison to other …
of lacidipine, a calcium channel blocker with a better tolerability in comparison to other …
Impact of calcium antagonists on the cardiovascular system: experience with lacidipine
E Kuschnir - Drugs, 1999 - Springer
The evaluation of haemodynamic patterns in hypertensive patients by radionuclide
techniques and a tomographic gamma camera has revealed differences between older and …
techniques and a tomographic gamma camera has revealed differences between older and …
Hagers Handbuch der Pharmazeutischen Praxis: Folgeband 5: Stoffe LZ
F Bruchhausen, S Ebel, E Hackenthal, U Holzgrabe… - 2013 - Springer
Hagers Handbuch der Pharmazeutischen Praxis: Folgeband 5: Stoffe LZ | SpringerLink Skip to
main content Advertisement SpringerLink Log in Menu Find a journal Publish with us Search …
main content Advertisement SpringerLink Log in Menu Find a journal Publish with us Search …
Prognostičko značenje hipertrofije lijeve klijetke u kardiovaskularnom kontinuumu
L Bosnar - 2017 - repozitorij.mef.unizg.hr
Kardiovaskularni (KV) kontinuum lanac je događaja precipitiranih brojnim
kardiovaskularnim faktorima rizika: dislipidemija, hipertenzija, dijabetes, pušenje i …
kardiovaskularnim faktorima rizika: dislipidemija, hipertenzija, dijabetes, pušenje i …
[PDF][PDF] Lasidipinin sıçanlarda indometazinle oluşturulan ülserlere etkisi
B Süleyman - atauni.edu.tr
Bu çalışmada, lasidipinin antiülser aktivitesi, sıçanlarda indometazinle oluşturulan ülser
modelinde araştırıldı ve antiülser aktivitesinin mide dokusundaki oksidan-antioksidan …
modelinde araştırıldı ve antiülser aktivitesinin mide dokusundaki oksidan-antioksidan …
[HTML][HTML] Реальные и потенциальные преимущества антагониста кальция III поколения лерканидипина
АА Кириченко - Системные гипертензии, 2013 - cyberleninka.ru
Рассмотрены особенности фармакокинетики дигидропиридинов III поколения
(фармакокинетика, контролируемая мембраной). Сравнительные исследования …
(фармакокинетика, контролируемая мембраной). Сравнительные исследования …